Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

People with androgenetic alopecia have more personality disorders and mental health symptoms; treatment may help.

Thyroid hormone may be useful for treating various skin conditions and needs more research.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Dogs with generalized discoid lupus erythematosus have similar symptoms to humans and need continuous treatment.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Treat pediatric skin issues with accurate diagnosis, multidisciplinary team, and various treatment options.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Testosterone's effects on COVID-19 are unclear and need more research.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Frankincense may help treat COVID-19, but more research is needed.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.